Posted inHealthcareLatest NewsUAE

Dubai’s DUPHAT 2023 saw $1.7bn deals signed

Pharmacy exhibition in Dubai saw an increase of 20% on last year’s commercial total

Duphat 2023 in Dubai
Dubai’s Duphat 2023 saw $1.7bn deals signed

Dubai’s DUPHAT concluded a successful week for pharmacy businesses with $1.66 (AED6.12bn), said organisers.

The 28th edition of the Dubai International Pharmacy Technologies Conference and Exhibition, DUPHAT 2023, generated exceptional interest from stakeholders across the pharmaceutical industry.

The commercial deal total is an increase of 20 percent from the previous year.

DUPHAT 2023

DUPHAT has been running for 28 years and is one of the Middle East and Africa region’s biggest scientific and medical events.

A total of 1,147 companies from 82 countries exhibited pharmaceutical and medical products at this year’s edition.

DUPHAT 2023, which attracted more than 26,000 visitors from around the world, also showcased a wide range of pharmaceutical innovation.

DUPHAT 2023

Dr. Abdul Salam Al Madani, Roving Ambassador for the Parliamentary Assembly of the Mediterranean for the GCC, and Executive Chairman of DUPHAT, said: “The AED6.12 billion worth of deals generated by DUPHAT 2023 reflect Dubai’s stature as one of the world’s leading commercial centres and a major healthcare and pharmaceutical hub.

“The vast interest attracted by the event signifies the scientific, academic, and commercial value it offers to both the public and private sectors in the industry.”

Stakeholders across the pharmaceutical industry to explore partnerships and commercial opportunities led to many local and international companies confirming their participation for upcoming editions of the event.

DUPHAT enables industry players to find new clients, suppliers and drug manufacturers.

Organisers expect participation in the next edition to increase by 30 percent.

The conference provided a forum for leading doctors and pharmaceutical experts from the US, Europe, the GCC, and other parts of the world to discuss the role played by pharmacists in curbing the spread of Covid-19.

Other issues discussed at this year’s event included the use of medication during pregnancy, clinical pharmacy practices, public health and therapeutic drug monitoring.

The event also provided an opportunity for pharmaceutical companies to launch new products, learn about new technologies and developments, acquire scientific knowledge, network with industry peers, exchange expertise and experiences with specialists in the sector and explore solutions to resolve challenges in the industry.

The next edition of the conference to be organised by INDEX Conferences and Exhibitions, a member of INDEX Holding, will take place in January 2024.

Follow us on

Author